Similarly, the DNM2-dependent endocytosis of the Interleukin 24 (IL-24) with its receptor is required in prostate cancer cells for the tumor suppressor action of the IL-24 (also called MDA-7) [72]. The gene discussed is DNM2; the disease is prostate carcinoma.